2-Amino-3-(Pidan-2-il)-Nafiridine (Quinine) -4-Ona, a receptor inhibitor of vascular endothelial growth factor R-3； formulation procedures； drugs； pharmacological synthesis； pharmacological combination； for the treatment of colon tumors, lymphomas, breast cancer, arthritis, cortitis, Glaucome A and inflammation, etc.
BRAUN ALAIN,DUCLOS OLIVIER,LASALLE GILBERT,LORGE FRANZ,STRUB AURELIE,MARTIN VALERIE,RITZELER OLAF
申请号：
CL2013003091
公开号：
CL2013003091A1
申请日:
2013.10.25
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The invention relates to the compounds of general formula (I): Preparation process and therapeutic use.COMPUESTOS DERIVADOS DE 2-AMINO-3-(IMIDAZOL-2-IL)-NAFTIRIDIN(QUINOLIN)-4-ONA, INHIBIDORES DEL RECEPTOR VEGF R-3； PROCEDIMIENTO PARA PREPARARLOS； MEDICAMENTO； COMPOSICION FARMACEUTICA； COMBINACION FARMACEUTICA； Y USO PARA TRATAR TUMORES SOLIDOS, LINFOMAS, CANCER DE MAMA, ARTROSIS, PSORIASIS, GLAUCOMA E INFLAMACION, ENTRE OTROS.
